BiTE-Based Immunotherapy Strategy Could Point the Way to a Breakthrough for Ovarian Cancer Patients
October 24, 2025
October 24, 2025
BUFFALO, New York, Oct. 24 [Category: BizHospital] -- The Roswell Park Comprehensive Cancer Center posted the following news release:
* * *
BiTE-Based Immunotherapy Strategy Could Point the Way to a Breakthrough for Ovarian Cancer Patients
*
BUFFALO, N.Y. Results of a study led by researchers at Roswell Park Comprehensive Cancer Center show that combining two types of immunotherapy engineered T cells that secrete bispecific T cell engagers (BiT . . .
* * *
BiTE-Based Immunotherapy Strategy Could Point the Way to a Breakthrough for Ovarian Cancer Patients
*
BUFFALO, N.Y. Results of a study led by researchers at Roswell Park Comprehensive Cancer Center show that combining two types of immunotherapy engineered T cells that secrete bispecific T cell engagers (BiT . . .
